Soleno Therapeutics, Inc. logo

SLNOSoleno Therapeutics, Inc.

SLNO Stock Price, Valuation & Chart | Soleno Therapeutics, Inc.

Compare
$53.010+0.00 (+0.00%)

At close · 15 May 2026, 08:00 pm

SLNO Historical price chart

SLNO Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization2.76B
PE Ratio27.47
EPS1.93
Trading Volume4.97M
Today's High/Low53.01/52.98
Dividend Yield0.00
52 Week High/Low90.32/29.43
Shares Outstanding52.12M
SLNO Financial Statement
SLNO Analyst ratings
SLNO Analysis & performance metrics

SLNO Company profile

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare…

SLNO Management team

Management
Anish Bhatnagar M.D.CEO
Chairman, President, Chief Executive Officer & Chief Operating Officer
Neil M. Cowen M.B.A., Ph.D.
Senior Vice President of Drug Development
Michael Huang M.D.
Senior Vice President of Clinical Development
Patricia C. Hirano M.P.H.
Senior Vice President of Regulatory Affairs
Mitchell Nagao M.B.A., Pharm.D.
Senior Vice President of Medical Affairs
Kristen Yen M.S.
Senior Vice President of Global Clinical Operations and Patient Advocacy
Meredith Manning M.B.A.
Chief Commercial Officer
Lauren Budesheim
Vice President of People
Total 8 executives

SLNO Frequently asked questions

What is Soleno Therapeutics, Inc. (SLNO) Stock Price?

Current stock price of Soleno Therapeutics, Inc. (SLNO) stock is $53.010. The stock price is +0.00% higher in the session. The intraday range can be seen from this page. Volume of Soleno Therapeutics, Inc. (SLNO) stock is 4.97M.

Last updated at 15 May 2026, 08:00 pm.

Why is the Soleno Therapeutics, Inc. (SLNO) stock price going up or down today?

The stock price of Soleno Therapeutics, Inc. (SLNO) can change with earnings, company news, and overall market sentiment. Soleno Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Soleno Therapeutics, Inc. stock expensive at its current price?

Whether Soleno Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for SLNO on this page is 27.47. EPS on this page is 1.93. Compare those figures with peers and growth expectations before deciding if the current Soleno Therapeutics, Inc. price is justified.

How has the stock price of Soleno Therapeutics, Inc. (SLNO) performed historically?

Historical performance for Soleno Therapeutics, Inc. (SLNO) is shown on the price chart on this page. Review multi-period moves alongside volume to see how SLNO reacted to past earnings and market events.

Should I buy Soleno Therapeutics, Inc. (SLNO) stock, at this price?

Buying Soleno Therapeutics, Inc. (SLNO) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.